Suppr超能文献

在斯洛伐克遗传性非息肉病性结直肠癌患者中鉴定出的MLH1和MSH2基因的新型和复发性种系改变。

Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.

作者信息

Zavodna K, Bujalkova M, Krivulcik T, Alemayehu A, Skorvaga M, Marra G, Fridrichova I, Jiricny J, Bartosova Z

机构信息

Laboratory of Cancer Genetics, Cancer Research Institute of Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic.

出版信息

Neoplasma. 2006;53(4):269-76.

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is associated with germline mutations in DNA mismatch repair genes, predominantly MSH2 and MLH1. Mutation carriers develop cancers in the colorectum, endometrium, ovary, stomach, small intestine and the upper urinary tract. We describe here the results of a mutational analysis of 11 unrelated HNPCC patients by direct genomic sequencing of MLH1 and MSH2. The alterations found include 7 novel changes and 4 different pathogenic mutations described previously in Poland, Moldavia, Finland, Germany, France and USA. Four novel pathogenic mutations in the MLH1 gene include two frameshift mutations (c.1150delG and c.1210_1211delCT), one missense mutation (c.793C>A) and one intron-exon border mutation (c.546- 2A>C). The last change resulted in the skipping of exon 7, as shown by sequencing of RT-PCR products. The only novel MSH2 pathogenic change was a nonsense mutation c.1129C>T. The novel intronic change c.381-41A>G in MLH1 was found in a patient carrying a previously-described mutation in the MSH2 gene. Interestingly, two unrelated patients carried also a novel change in the promoter region of MLH1 in one of the CpG islands (c.-269C>G). However, this alteration does not abrogate transcription, as shown by RT-PCR analysis. In summary, most (approximately 80%) pathogenic germline mutations detected in the studied group of patients by direct genomic sequencing of MLH1 and MSH2 were located in the MLH1 gene. These and previous data indicate that the majority of germline point mutations and small deletions/insertions in HNPCC families in Slovakia affect the MLH1 locus.

摘要

遗传性非息肉病性结直肠癌(HNPCC)与DNA错配修复基因的种系突变相关,主要是MSH2和MLH1。突变携带者会在结肠、子宫内膜、卵巢、胃、小肠和上尿路发生癌症。我们在此描述了通过对MLH1和MSH2进行直接基因组测序,对11名无亲缘关系的HNPCC患者进行突变分析的结果。发现的改变包括7种新变化和4种先前在波兰、摩尔多瓦、芬兰、德国、法国和美国描述过的不同致病突变。MLH1基因中的4种新致病突变包括两种移码突变(c.1150delG和c.1210_1211delCT)、一种错义突变(c.793C>A)和一种内含子-外显子边界突变(c.546-2A>C)。如RT-PCR产物测序所示,最后一种变化导致外显子7跳跃。唯一新的MSH2致病变化是一种无义突变c.1129C>T。在一名携带先前描述的MSH2基因突变的患者中发现了MLH1基因中新的内含子变化c.381-41A>G。有趣的是,两名无亲缘关系的患者在其中一个CpG岛的MLH1启动子区域也携带一种新变化(c.-269C>G)。然而,如RT-PCR分析所示,这种改变不会消除转录。总之,通过对MLH1和MSH2进行直接基因组测序,在所研究的患者组中检测到的大多数(约80%)致病种系突变位于MLH1基因中。这些以及先前的数据表明,斯洛伐克HNPCC家族中的大多数种系点突变和小缺失/插入影响MLH1基因座。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验